Adaptimmune Therapeutics PLC (ADAP)

This company has so much hope.......... it just takes patience. what'a everyone's cost average?

$ADAPY New CEO CHRIS HILL is bringing in connection with Key Investor Oxford from the UK . See Bio
https://www.adaptimmune.com/our-company/board-of-directors#members-2

$ADAPY One has to KNOW that many step must be taken when tranferring to the OTC . First Giant Dollar savings going to the OTC as NASDAQ fees are in the six digit range per year.
Also follow the SEC Filings , this one is the most important as NOW ADAPY can be traded freely with this Filing just done , which is the last step needed.
https://www.otcmarkets.com/filing/html?id=18930394&guid=is8-kePL-zvCJth
not sure what it is , see here.
Quote
" A SEC notice of effectiveness is a public announcement from the Securities and Exchange Commission (SEC) stating that a company's registration statement has become effective. This marks the date when the company can begin selling securities to the public, such as through an Initial Public Offering (IPO). The SEC posts these notices electronically on its EDGAR system."

Adap is gone 🤮

This is just part of the cost , there is more by far
===
quote
"Listing on the Nasdaq is significantly more expensive than on the OTC markets, with initial fees ranging from approximately $50,000 to $75,000 for Nasdaq, compared to $5,000 for OTCQX and $1,000 for OTC Pink"

Ballpark saving for not staying listed??

Hmm Lets see here. It cost a LOT OF MONEY TO STAY LISTED...

Or I am missing here. I was referring, based on what I read, is that the delisting was voluntary rather than forced. Either way, I may have made a mistake in buying in the first place but I will see tomorrow.

What do you mean as a fact? They filed the 8K. What am I missing here?

I bought 164K shares on the premise that this will recover part of the large drop it experienced but only time will tell. I did not see anything about delisting as a fact. Company has the usual time to correct problems and if it does not then there may be a delisting but not yet.

Wow! Big drop, guess the delisting was real

We headed back up! Let's gooo

Good morning Jus 😃 nice start.

$ADAP

Brother it looks like another vivk !

$0.26+

$ADAP 💹

$0.23+

$ADAP 💹

$ADAP Check out the Company Website. It has cleaned up debt , becomed Lean and Mean , potential for Buy Out is STRONG.
https://www.adaptimmune.com/

short squeeze might = coming news.

ADAP.....................https://stockcharts.com/h-sc/ui?s=ADAP&p=W&b=5&g=0&id=p86431144783

$ADAP +15% AH 🚀
🔹 Momentum building after $55M upfront deal with US WorldMeds + $30M milestones 💰🔹 Tecelra sales surged 150% QoQ to $11.1M – 16 patients invoiced 📈🔹 Debt repaid, restructuring underway to sharpen focus on PRAME & CD70 T-cell programs 🧬🔹 ATC network nearing completion with ~30 treatment centers live💥💥💥💎💎💎

Here we go!!!

$0.24+ 😃

$ADAP 💹

ADAP - Trying again!

$ADAP

ADAP.........................................................p/m

$ADAP Well this came out yesterday 9/26 on a 8-K , another notice now on the Share Price. Hmmmm, lets see what they do as they now have an extention until Dec 1 2025 to correct that. One tends to think which way it will go , but time will tell, TBD
here is the link
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001621227/000110465925093882/adap-20250922x8k.htm

ADAP................................https://stockcharts.com/h-sc/ui?s=ADAP&p=W&b=5&g=0&id=p86431144783

$ADAP , Do NOT BELIEVE False postings of people doing AI or Chat PT searches on R/S information .
--
THERE IS NO , REPEAT NO REVERSE SPLIT MENTIONED ANYWHERE.
--
This was based on a RULE situation and the company has until MARCH 2026 (past Halloween, Turkey Day, Xmas , New Years, Valentines Day )
so one should not be to worried about anything there.
---
Quote
" the Company has 180 calendar days, or until March 10, 2026, to regain compliance with the MVLS Listing Rule. In order to regain compliance with the MVLS Listing Rule, "
--
Read the Disclosures , not opinions and false news from "Debbie or Donnie Downers" , here you go
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001621227/000110465925089558/adap-20250911x8k.htm

$ADAP Folks LEARN HOW TO READ DISCLOSURES and not listen to doomsday negative folks trying to get shares at lower prices or shorting stocks like this. ADAP (Adaptimmune) has Millions of Dollars in CASH , Revenue and has until MARCH OF 2026 to get back on any Responses . There is no, NO Reverse Stock Split mentioned , announced, stated, thought of in any statement , filing from the Company . Learn to check on the DD , see this Link I always provide. ( one has to wonder why the bashers NEVER provide links).
see here
https://www.adaptimmune.com/our-company
Go to their website, see the Mgt Bios, go to the Investors link shows all the filings and PR. Go to the lastest 8-K filed this MONTH (see link below there is NO REVERSE split talked about NONE)
https://www.adaptimmune.com/investors-and-media/sec-filings/all-sec-filings/content/0001104659-25-089558/0001104659-25-089558.pdf
Quote
" The Notice has no immediate effect on the listing or trading of the Company’s American Depositary Shares (“ADSs”) on The Nasdaq Capital Market.
However, if the Company fails to timely regain compliance with the MVLS Listing Rule by March 10, 2026,"
--
Lets go folks , do your DD and open links to DATA POINTS to see for yourself. This is being shorted and maniplutated.

ADAP.........................https://stockcharts.com/h-sc/ui?s=ADAP&p=W&b=5&g=0&id=p86431144783

ADAP - Looks like it. Nice few days for sure!

Warning! They're dumping 1.6 Billion worthless shares to the fools.

Good morning buddy 😄
It run well yesterday.

$ADAP

Another mover?

ADAPTIMMUNE THERAPEUTICS PLC

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

They have $26 million in cash!

https://www.otcmarkets.com/filing/html?id=18688568&guid=LsZ-kqWDgxw-B3h

WOW!!! ADAP: cash: $11k, revenue: $25k, O/S: 1.6 Billion Shares !!!

https://www.otcmarkets.com/filing/html?id=18688568&guid=LsZ-kqWDgxw-B3h

$0.22+ 😃

$ADAP

ADAP - Not a bad day!

They'll announce Huge R/S, or be Delisted. Dumping huge before it.

ADAP, 1.6 Billion shares Dumping: Shares Issued 1,590,310,000

$0.14+ 😃

$ADAP

$0.11+ 😃

$ADAP

$0.095 😃

$ADAP

desperately short?

$ADAP moving.

====================

On September 11, 2025, Adaptimmune Therapeutics plc (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 32 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “MVLS Listing Rule”). Additionally, as of the date of the Notice, the Company did not meet either of the alternative Nasdaq continued listing standards under the Nasdaq Listing Rules: stockholders’ equity of at least $2.5 million or net income of $500,000 from continuing operations in the most recently completed fiscal year or in two of the three most recently completed fiscal years. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days, or until March 10, 2026, to regain compliance with the MVLS Listing Rule. In order to regain compliance with the MVLS Listing Rule, the Company’s MVLS must meet or exceed $35.0 million for a minimum of ten consecutive business days during the 180-day compliance period after which the Staff will provide to the Company written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with the MVLS Listing Rule during the 180-day compliance period, the Staff will provide the Company notice that the Company’s securities will be subject to delisting, at which time, the Company may appeal the delisting determination to a Nasdaq hearings panel.

The Notice has no immediate effect on the listing or trading of the Company’s American Depositary Shares (“ADSs”) on The Nasdaq Capital Market. However, if the Company fails to timely regain compliance with the MVLS Listing Rule by March 10, 2026, the Company’s ADSs will be subject to delisting from Nasdaq at which time the Company may appeal the delisting determination to a Nasdaq hearings panel. The Company will continue to monitor its MVLS and consider its available options to regain compliance with the MVLS Listing Rule. There can be no assurance that the Company will regain compliance with the MVLS Listing Rule or otherwise maintain compliance with any of the other Nasdaq listing requirements.

https://investorshub.advfn.com/stock-market/NASDAQ/adaptimmune-therapeutics-ADAP/stock-news/96812354/form-8-k-current-report

==================

Adaptimmune Appoints New CFO Christopher Hill

Adaptimmune Therapeutics ( (ADAP) ) just unveiled an announcement.

On September 6, 2025, Adaptimmune Limited appointed Christopher Hill as Chief Financial Officer, effective September 10, 2025. Hill, with over a decade of experience in financial roles within life science companies, will manage the company’s accounting and finance functions as an independent contractor through a consulting agreement with CJH Financial Limited. This strategic appointment highlights Adaptimmune’s focus on strengthening its financial leadership as it continues to develop its therapeutic offerings.

The most recent analyst rating on (ADAP) stock is a Sell with a $0.46 price target. To see the full list of analyst forecasts on Adaptimmune Therapeutics stock, see the ADAP Stock Forecast page.

Spark’s Take on ADAP Stock
According to Spark, TipRanks’ AI Analyst, ADAP is a Neutral.

Adaptimmune Therapeutics’ overall stock score is primarily impacted by its weak financial performance and valuation, reflecting significant financial instability and ongoing losses. Technical analysis also indicates bearish momentum. While the earnings call provided some operational positives, recent corporate events, including executive changes and a delisting notice, further contribute to a cautious outlook.

More about Adaptimmune Therapeutics
Adaptimmune Therapeutics is a company operating in the life sciences industry, focusing on developing therapies for autoimmune and fibrotic diseases. The company engages in drug development, with assets ranging from pre-clinical to phase IIb stages.

Average Trading Volume: 35,692,422
Technical Sentiment Signal: Sell
Current Market Cap: $10.87M

https://www.msn.com/en-us/money/topstocks/adaptimmune-appoints-new-cfo-christopher-hill/ar-AA1M9nf7

$ADAP

THEY DO "NOT" 🚫 HAVE "UNTIL" ( OCTOBER 27, 2025 ) "ANYMORE"...

THEY "ALREADY" "RECEIVED" A "NEW" "IMMEDIATE" "NASDAQ DELISTING NOTICE" ON ( AUGUST 14, 2025 ) FOR "CLOSING" "AT OR BELOW" ( $0.10 ) FOR ( 10 ) "CONSECUTIVE" "DAYS"...

IF THEY DO "NOT" 🚫 "SHOW" "NASDAQ" AT THEIR "NASDAQ DELISTING HEARING" THAT THEY ARE "GOING" TO "FIX" THIS "IMMEDIATELY" THEY "WILL" BE "DELISTED"...

"REVERSE SPLIT" "WILL" BE IN THEIR "PLAN" TO "REGAIN" "COMPLIANCE" THAT THEY "PRESENT" TO "NASDAQ" AT THEIR "DELISTING HEARING"

THAT WAS SOME "HEAVY" "PICK POCKETING" "BEFORE" THE "REVERSE SPLIT" "DATE" "ANNOUNCEMENT" TO "REGAIN" "NASDAQ COMPLIANCE"

"NASDAQ DELISTING NOTICE" "ALREADY" "RECEIVED" "HALF A MONTH AGO" ( AUGUST 14, 2025 )

"ALL" THE "KEY" "BOARD MEMBERS" "ALREADY" "OUIT"

"REVERSE SPLIT" "DATE" "ANNOUNCEMENT" "IMMINENT"...

OR GET "DELISTED"...

"NASDAQ DELISTING NOTICE" "ALREADY" "RECEIVED" ( AUGUST 14, 2025 )

THE "COMPANY" IS "GOING TO BE" "DELISTED" IF THEY DO "NOT" 🚫 "REVERSE SPLIT"